TVTX · Travere Therapeutics, Inc.

$67.52 +0.40 (+0.60%) At close · Aug 27

Market Cap

$6.33B

94.26M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
Investor Event Transcript	2026-08-11	2026-09-30
10-Q	2026-08-04	2026-06-30
8-K	2026-08-04	—
8-K	2026-07-09	2026-07-06
8-K	2026-06-16	2026-06-12
Investor Event Transcript	2026-06-08	2026-06-30
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-06-02	2026-06-01
8-K	2026-05-21	2026-05-19
8-K	2026-05-11	2026-05-06
8-K	2026-05-04	—
10-Q	2026-05-04	2026-03-31
8-K	2026-04-14	2026-04-13
Investor Event Transcript	2026-04-13	2026-06-30
DEF 14A	2026-04-06	2026-05-19
10-K	2026-02-19	2025-12-31
8-K	2026-02-19	—
8-K	2026-01-13	—
8-K	2026-01-12	—
10-Q	2025-10-30	2025-09-30
8-K	2025-10-30	—
8-K	2025-09-10	—
10-Q	2025-08-06	2025-06-30
8-K	2025-08-06	—
8-K	2025-05-16	2025-05-15
8-K	2025-05-15	—
8-K/A	2025-05-01	—
8-K	2025-05-01	—
10-Q	2025-05-01	2025-03-31
8-K	2025-04-30	2025-04-29
DEF 14A	2025-04-01	2025-05-15
8-K	2025-03-17	—
10-K	2025-02-21	2024-12-31
8-K	2025-02-20	—
8-K	2025-02-11	—
8-K	2025-01-13	—
8-K	2024-11-08	2024-11-07
10-Q	2024-10-31	2024-09-30
8-K	2024-10-31	—
8-K	2024-09-26	—
8-K	2024-09-06	2024-09-05
10-Q	2024-08-01	2024-06-30
8-K	2024-08-01	—
8-K	2024-05-13	2024-05-08
10-Q	2024-05-06	2024-03-31
8-K	2024-05-06	—
8-K	2024-04-24	—
DEF 14A	2024-03-27	2024-05-08
8-K	2024-02-23	—
10-K	2024-02-20	2023-12-31

Showing 1–50 of 136 filings

Key facts CIK 1438533 CUSIP 89422G107 13F (30d) 282 filings 278 filers Visit website Investor relations